ADHD（注意欠如・多動性障害）治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global ADHD Treatment Market Insights, Forecast to 2028

• レポートコード：QY2207E10350 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のADHD（注意欠如・多動性障害）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にADHD（注意欠如・多動性障害）治療の世界市場のxxx％を占める「覚醒剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のADHD（注意欠如・多動性障害）治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのADHD（注意欠如・多動性障害）治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのADHD（注意欠如・多動性障害）治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ADHD（注意欠如・多動性障害）治療のグローバル主要メーカーには、Takeda、Johnson & Johnson、N ovartis、Eli Lilly、Tris Pharma、Neos Therapeutics、Mallinckrodt、Amneal Pharmaceuticals、N oven Pharmaceuticals、Purdue Parma、Jiangsu Chia Tai Fenghai Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ADHD（注意欠如・多動性障害）治療市場は、種類と用途によって区分されます。世界のADHD（注意欠如・多動性障害）治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 覚醒剤、非覚醒剤 【用途別セグメント】 病院薬局、小売店薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ADHD（注意欠如・多動性障害）治療製品概要 - 種類別市場（覚醒剤、非覚醒剤） - 用途別市場（病院薬局、小売店薬局） - 調査の目的 ・エグゼクティブサマリー - 世界のADHD（注意欠如・多動性障害）治療販売量予測2017-2028 - 世界のADHD（注意欠如・多動性障害）治療売上予測2017-2028 - ADHD（注意欠如・多動性障害）治療の地域別販売量 - ADHD（注意欠如・多動性障害）治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ADHD（注意欠如・多動性障害）治療販売量 - 主要メーカー別ADHD（注意欠如・多動性障害）治療売上 - 主要メーカー別ADHD（注意欠如・多動性障害）治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（覚醒剤、非覚醒剤） - ADHD（注意欠如・多動性障害）治療の種類別販売量 - ADHD（注意欠如・多動性障害）治療の種類別売上 - ADHD（注意欠如・多動性障害）治療の種類別価格 ・用途別市場規模（病院薬局、小売店薬局） - ADHD（注意欠如・多動性障害）治療の用途別販売量 - ADHD（注意欠如・多動性障害）治療の用途別売上 - ADHD（注意欠如・多動性障害）治療の用途別価格 ・北米市場 - 北米のADHD（注意欠如・多動性障害）治療市場規模（種類別、用途別） - 主要国別のADHD（注意欠如・多動性障害）治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのADHD（注意欠如・多動性障害）治療市場規模（種類別、用途別） - 主要国別のADHD（注意欠如・多動性障害）治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のADHD（注意欠如・多動性障害）治療市場規模（種類別、用途別） - 主要国別のADHD（注意欠如・多動性障害）治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のADHD（注意欠如・多動性障害）治療市場規模（種類別、用途別） - 主要国別のADHD（注意欠如・多動性障害）治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのADHD（注意欠如・多動性障害）治療市場規模（種類別、用途別） - 主要国別のADHD（注意欠如・多動性障害）治療市場規模（トルコ、サウジアラビア） ・企業情報 Takeda、Johnson & Johnson、N ovartis、Eli Lilly、Tris Pharma、Neos Therapeutics、Mallinckrodt、Amneal Pharmaceuticals、N oven Pharmaceuticals、Purdue Parma、Jiangsu Chia Tai Fenghai Pharmaceutical ・産業チェーン及び販売チャネル分析 - ADHD（注意欠如・多動性障害）治療の産業チェーン分析 - ADHD（注意欠如・多動性障害）治療の原材料 - ADHD（注意欠如・多動性障害）治療の生産プロセス - ADHD（注意欠如・多動性障害）治療の販売及びマーケティング - ADHD（注意欠如・多動性障害）治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ADHD（注意欠如・多動性障害）治療の産業動向 - ADHD（注意欠如・多動性障害）治療のマーケットドライバー - ADHD（注意欠如・多動性障害）治療の課題 - ADHD（注意欠如・多動性障害）治療の阻害要因 ・主な調査結果

Attention deficit and hyperactivity disorder (ADHD), commonly known as ADHD, refers to the occurrence of childhood,A group of syndromes characterized by marked difficulty concentrating, short attention span, hyperactivity, or impulsivity compared with children of the same age. To treat ADHD, the US FDA has approved two types of drugs: stimulants and non-stimulants. Stimulants include methylphenidate, amphetamines Amphetamine, non-stimulants including atomoxetine, guanfacine and clonidine.
Market Analysis and Insights: Global ADHD Treatment Market
Due to the COVID-19 pandemic, the global ADHD Treatment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Stimulant accounting for % of the ADHD Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China ADHD Treatment market size is valued at US$ million in 2021, while the US and Europe ADHD Treatment are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe ADHD Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of ADHD Treatment include Takeda, Johnson & Johnson, N ovartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and N oven Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global ADHD Treatment Scope and Segment
ADHD Treatment market is segmented by Type and by Distribution Channel. Players, stakeholders, and other participants in the global ADHD Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Distribution Channel for the period 2017-2028.
Segment by Type
Stimulant
Non-stimulant
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
By Company
Takeda
Johnson & Johnson
N ovartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
N oven Pharmaceuticals
Purdue Parma
Jiangsu Chia Tai Fenghai Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 ADHD Treatment Product Introduction
1.2 Market by Type
1.2.1 Global ADHD Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Distribution Channel
1.3.1 Global ADHD Treatment Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global ADHD Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global ADHD Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global ADHD Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global ADHD Treatment Sales by Region
2.4.1 Global ADHD Treatment Sales by Region (2017-2022)
2.4.2 Global Sales ADHD Treatment by Region (2023-2028)
2.5 Global ADHD Treatment Revenue by Region
2.5.1 Global ADHD Treatment Revenue by Region (2017-2022)
2.5.2 Global ADHD Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global ADHD Treatment Sales by Manufacturers
3.1.1 Global Top ADHD Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global ADHD Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of ADHD Treatment in 2021
3.2 Global ADHD Treatment Revenue by Manufacturers
3.2.1 Global ADHD Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global ADHD Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by ADHD Treatment Revenue in 2021
3.3 Global ADHD Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global ADHD Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global ADHD Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global ADHD Treatment Sales by Type
4.1.1 Global ADHD Treatment Historical Sales by Type (2017-2022)
4.1.2 Global ADHD Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global ADHD Treatment Sales Market Share by Type (2017-2028)
4.2 Global ADHD Treatment Revenue by Type
4.2.1 Global ADHD Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global ADHD Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global ADHD Treatment Revenue Market Share by Type (2017-2028)
4.3 Global ADHD Treatment Price by Type
4.3.1 Global ADHD Treatment Price by Type (2017-2022)
4.3.2 Global ADHD Treatment Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
5.1 Global ADHD Treatment Sales by Distribution Channel
5.1.1 Global ADHD Treatment Historical Sales by Distribution Channel (2017-2022)
5.1.2 Global ADHD Treatment Forecasted Sales by Distribution Channel (2023-2028)
5.1.3 Global ADHD Treatment Sales Market Share by Distribution Channel (2017-2028)
5.2 Global ADHD Treatment Revenue by Distribution Channel
5.2.1 Global ADHD Treatment Historical Revenue by Distribution Channel (2017-2022)
5.2.2 Global ADHD Treatment Forecasted Revenue by Distribution Channel (2023-2028)
5.2.3 Global ADHD Treatment Revenue Market Share by Distribution Channel (2017-2028)
5.3 Global ADHD Treatment Price by Distribution Channel
5.3.1 Global ADHD Treatment Price by Distribution Channel (2017-2022)
5.3.2 Global ADHD Treatment Price Forecast by Distribution Channel (2023-2028)
6 North America
6.1 North America ADHD Treatment Market Size by Type
6.1.1 North America ADHD Treatment Sales by Type (2017-2028)
6.1.2 North America ADHD Treatment Revenue by Type (2017-2028)
6.2 North America ADHD Treatment Market Size by Distribution Channel
6.2.1 North America ADHD Treatment Sales by Distribution Channel (2017-2028)
6.2.2 North America ADHD Treatment Revenue by Distribution Channel (2017-2028)
6.3 North America ADHD Treatment Market Size by Country
6.3.1 North America ADHD Treatment Sales by Country (2017-2028)
6.3.2 North America ADHD Treatment Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe ADHD Treatment Market Size by Type
7.1.1 Europe ADHD Treatment Sales by Type (2017-2028)
7.1.2 Europe ADHD Treatment Revenue by Type (2017-2028)
7.2 Europe ADHD Treatment Market Size by Distribution Channel
7.2.1 Europe ADHD Treatment Sales by Distribution Channel (2017-2028)
7.2.2 Europe ADHD Treatment Revenue by Distribution Channel (2017-2028)
7.3 Europe ADHD Treatment Market Size by Country
7.3.1 Europe ADHD Treatment Sales by Country (2017-2028)
7.3.2 Europe ADHD Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific ADHD Treatment Market Size by Type
8.1.1 Asia Pacific ADHD Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific ADHD Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific ADHD Treatment Market Size by Distribution Channel
8.2.1 Asia Pacific ADHD Treatment Sales by Distribution Channel (2017-2028)
8.2.2 Asia Pacific ADHD Treatment Revenue by Distribution Channel (2017-2028)
8.3 Asia Pacific ADHD Treatment Market Size by Region
8.3.1 Asia Pacific ADHD Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific ADHD Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America ADHD Treatment Market Size by Type
9.1.1 Latin America ADHD Treatment Sales by Type (2017-2028)
9.1.2 Latin America ADHD Treatment Revenue by Type (2017-2028)
9.2 Latin America ADHD Treatment Market Size by Distribution Channel
9.2.1 Latin America ADHD Treatment Sales by Distribution Channel (2017-2028)
9.2.2 Latin America ADHD Treatment Revenue by Distribution Channel (2017-2028)
9.3 Latin America ADHD Treatment Market Size by Country
9.3.1 Latin America ADHD Treatment Sales by Country (2017-2028)
9.3.2 Latin America ADHD Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa ADHD Treatment Market Size by Type
10.1.1 Middle East and Africa ADHD Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa ADHD Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa ADHD Treatment Market Size by Distribution Channel
10.2.1 Middle East and Africa ADHD Treatment Sales by Distribution Channel (2017-2028)
10.2.2 Middle East and Africa ADHD Treatment Revenue by Distribution Channel (2017-2028)
10.3 Middle East and Africa ADHD Treatment Market Size by Country
10.3.1 Middle East and Africa ADHD Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa ADHD Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Overview
11.1.3 Takeda ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Takeda ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 N ovartis
11.3.1 N ovartis Corporation Information
11.3.2 N ovartis Overview
11.3.3 N ovartis ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 N ovartis ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 N ovartis Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Tris Pharma
11.5.1 Tris Pharma Corporation Information
11.5.2 Tris Pharma Overview
11.5.3 Tris Pharma ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tris Pharma ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tris Pharma Recent Developments
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Corporation Information
11.6.2 Neos Therapeutics Overview
11.6.3 Neos Therapeutics ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Neos Therapeutics ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Neos Therapeutics Recent Developments
11.7 Mallinckrodt
11.7.1 Mallinckrodt Corporation Information
11.7.2 Mallinckrodt Overview
11.7.3 Mallinckrodt ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mallinckrodt ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mallinckrodt Recent Developments
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Corporation Information
11.8.2 Amneal Pharmaceuticals Overview
11.8.3 Amneal Pharmaceuticals ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Amneal Pharmaceuticals ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amneal Pharmaceuticals Recent Developments
11.9 N oven Pharmaceuticals
11.9.1 N oven Pharmaceuticals Corporation Information
11.9.2 N oven Pharmaceuticals Overview
11.9.3 N oven Pharmaceuticals ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 N oven Pharmaceuticals ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 N oven Pharmaceuticals Recent Developments
11.10 Purdue Parma
11.10.1 Purdue Parma Corporation Information
11.10.2 Purdue Parma Overview
11.10.3 Purdue Parma ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Purdue Parma ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Purdue Parma Recent Developments
11.11 Jiangsu Chia Tai Fenghai Pharmaceutical
11.11.1 Jiangsu Chia Tai Fenghai Pharmaceutical Corporation Information
11.11.2 Jiangsu Chia Tai Fenghai Pharmaceutical Overview
11.11.3 Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 ADHD Treatment Industry Chain Analysis
12.2 ADHD Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 ADHD Treatment Production Mode & Process
12.4 ADHD Treatment Sales and Marketing
12.4.1 ADHD Treatment Sales Channels
12.4.2 ADHD Treatment Distributors
12.5 ADHD Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 ADHD Treatment Industry Trends
13.2 ADHD Treatment Market Drivers
13.3 ADHD Treatment Market Challenges
13.4 ADHD Treatment Market Restraints
14 Key Findings in The Global ADHD Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global ADHD Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Stimulant
Table 3. Major Manufacturers of Non-stimulant
Table 4. Global ADHD Treatment Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global ADHD Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global ADHD Treatment Sales by Region (2017-2022) & (K Units)
Table 7. Global ADHD Treatment Sales Market Share by Region (2017-2022)
Table 8. Global ADHD Treatment Sales by Region (2023-2028) & (K Units)
Table 9. Global ADHD Treatment Sales Market Share by Region (2023-2028)
Table 10. Global ADHD Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global ADHD Treatment Revenue Market Share by Region (2017-2022)
Table 12. Global ADHD Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global ADHD Treatment Revenue Market Share by Region (2023-2028)
Table 14. Global ADHD Treatment Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global ADHD Treatment Sales Share by Manufacturers (2017-2022)
Table 16. Global ADHD Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global ADHD Treatment Revenue Share by Manufacturers (2017-2022)
Table 18. ADHD Treatment Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global ADHD Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global ADHD Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Treatment as of 2021)
Table 21. ADHD Treatment Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers ADHD Treatment Product Offered
Table 23. Date of Manufacturers Enter into ADHD Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global ADHD Treatment Sales by Type (2017-2022) & (K Units)
Table 26. Global ADHD Treatment Sales by Type (2023-2028) & (K Units)
Table 27. Global ADHD Treatment Sales Share by Type (2017-2022)
Table 28. Global ADHD Treatment Sales Share by Type (2023-2028)
Table 29. Global ADHD Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global ADHD Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global ADHD Treatment Revenue Share by Type (2017-2022)
Table 32. Global ADHD Treatment Revenue Share by Type (2023-2028)
Table 33. ADHD Treatment Price by Type (2017-2022) & (US$/Unit)
Table 34. Global ADHD Treatment Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global ADHD Treatment Sales by Distribution Channel (2017-2022) & (K Units)
Table 36. Global ADHD Treatment Sales by Distribution Channel (2023-2028) & (K Units)
Table 37. Global ADHD Treatment Sales Share by Distribution Channel (2017-2022)
Table 38. Global ADHD Treatment Sales Share by Distribution Channel (2023-2028)
Table 39. Global ADHD Treatment Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 40. Global ADHD Treatment Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 41. Global ADHD Treatment Revenue Share by Distribution Channel (2017-2022)
Table 42. Global ADHD Treatment Revenue Share by Distribution Channel (2023-2028)
Table 43. ADHD Treatment Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 44. Global ADHD Treatment Price Forecast by Distribution Channel (2023-2028) & (US$/Unit)
Table 45. North America ADHD Treatment Sales by Type (2017-2022) & (K Units)
Table 46. North America ADHD Treatment Sales by Type (2023-2028) & (K Units)
Table 47. North America ADHD Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America ADHD Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America ADHD Treatment Sales by Distribution Channel (2017-2022) & (K Units)
Table 50. North America ADHD Treatment Sales by Distribution Channel (2023-2028) & (K Units)
Table 51. North America ADHD Treatment Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 52. North America ADHD Treatment Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 53. North America ADHD Treatment Sales by Country (2017-2022) & (K Units)
Table 54. North America ADHD Treatment Sales by Country (2023-2028) & (K Units)
Table 55. North America ADHD Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America ADHD Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe ADHD Treatment Sales by Type (2017-2022) & (K Units)
Table 58. Europe ADHD Treatment Sales by Type (2023-2028) & (K Units)
Table 59. Europe ADHD Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe ADHD Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe ADHD Treatment Sales by Distribution Channel (2017-2022) & (K Units)
Table 62. Europe ADHD Treatment Sales by Distribution Channel (2023-2028) & (K Units)
Table 63. Europe ADHD Treatment Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 64. Europe ADHD Treatment Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 65. Europe ADHD Treatment Sales by Country (2017-2022) & (K Units)
Table 66. Europe ADHD Treatment Sales by Country (2023-2028) & (K Units)
Table 67. Europe ADHD Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe ADHD Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific ADHD Treatment Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific ADHD Treatment Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific ADHD Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific ADHD Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific ADHD Treatment Sales by Distribution Channel (2017-2022) & (K Units)
Table 74. Asia Pacific ADHD Treatment Sales by Distribution Channel (2023-2028) & (K Units)
Table 75. Asia Pacific ADHD Treatment Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 76. Asia Pacific ADHD Treatment Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 77. Asia Pacific ADHD Treatment Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific ADHD Treatment Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific ADHD Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific ADHD Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America ADHD Treatment Sales by Type (2017-2022) & (K Units)
Table 82. Latin America ADHD Treatment Sales by Type (2023-2028) & (K Units)
Table 83. Latin America ADHD Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America ADHD Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America ADHD Treatment Sales by Distribution Channel (2017-2022) & (K Units)
Table 86. Latin America ADHD Treatment Sales by Distribution Channel (2023-2028) & (K Units)
Table 87. Latin America ADHD Treatment Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 88. Latin America ADHD Treatment Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 89. Latin America ADHD Treatment Sales by Country (2017-2022) & (K Units)
Table 90. Latin America ADHD Treatment Sales by Country (2023-2028) & (K Units)
Table 91. Latin America ADHD Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America ADHD Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa ADHD Treatment Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa ADHD Treatment Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa ADHD Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa ADHD Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa ADHD Treatment Sales by Distribution Channel (2017-2022) & (K Units)
Table 98. Middle East and Africa ADHD Treatment Sales by Distribution Channel (2023-2028) & (K Units)
Table 99. Middle East and Africa ADHD Treatment Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 100. Middle East and Africa ADHD Treatment Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 101. Middle East and Africa ADHD Treatment Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa ADHD Treatment Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa ADHD Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa ADHD Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 105. Takeda Corporation Information
Table 106. Takeda Description and Major Businesses
Table 107. Takeda ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Takeda ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Takeda Recent Developments
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Major Businesses
Table 112. Johnson & Johnson ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Johnson & Johnson ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Johnson & Johnson Recent Developments
Table 115. N ovartis Corporation Information
Table 116. N ovartis Description and Major Businesses
Table 117. N ovartis ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. N ovartis ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. N ovartis Recent Developments
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Major Businesses
Table 122. Eli Lilly ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Eli Lilly ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Eli Lilly Recent Developments
Table 125. Tris Pharma Corporation Information
Table 126. Tris Pharma Description and Major Businesses
Table 127. Tris Pharma ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Tris Pharma ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Tris Pharma Recent Developments
Table 130. Neos Therapeutics Corporation Information
Table 131. Neos Therapeutics Description and Major Businesses
Table 132. Neos Therapeutics ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Neos Therapeutics ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Neos Therapeutics Recent Developments
Table 135. Mallinckrodt Corporation Information
Table 136. Mallinckrodt Description and Major Businesses
Table 137. Mallinckrodt ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Mallinckrodt ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Mallinckrodt Recent Developments
Table 140. Amneal Pharmaceuticals Corporation Information
Table 141. Amneal Pharmaceuticals Description and Major Businesses
Table 142. Amneal Pharmaceuticals ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Amneal Pharmaceuticals ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Amneal Pharmaceuticals Recent Developments
Table 145. N oven Pharmaceuticals Corporation Information
Table 146. N oven Pharmaceuticals Description and Major Businesses
Table 147. N oven Pharmaceuticals ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. N oven Pharmaceuticals ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. N oven Pharmaceuticals Recent Developments
Table 150. Purdue Parma Corporation Information
Table 151. Purdue Parma Description and Major Businesses
Table 152. Purdue Parma ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Purdue Parma ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Purdue Parma Recent Developments
Table 155. Jiangsu Chia Tai Fenghai Pharmaceutical Corporation Information
Table 156. Jiangsu Chia Tai Fenghai Pharmaceutical Description and Major Businesses
Table 157. Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. ADHD Treatment Distributors List
Table 163. ADHD Treatment Customers List
Table 164. ADHD Treatment Market Trends
Table 165. ADHD Treatment Market Drivers
Table 166. ADHD Treatment Market Challenges
Table 167. ADHD Treatment Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. ADHD Treatment Product Picture
Figure 3. Global ADHD Treatment Market Share by Type in 2021 & 2028
Figure 3. Stimulant Product Picture
Figure 4. Non-stimulant Product Picture
Figure 5. Global ADHD Treatment Market Share by Distribution Channel in 2021 & 2028
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. ADHD Treatment Report Years Considered
Figure 9. Global ADHD Treatment Sales 2017-2028 (K Units)
Figure 10. Global ADHD Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global ADHD Treatment Revenue 2017-2028 (US$ Million)
Figure 12. Global ADHD Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global ADHD Treatment Sales Market Share by Region (2017-2022)
Figure 14. Global ADHD Treatment Sales Market Share by Region (2023-2028)
Figure 15. North America ADHD Treatment Sales YoY (2017-2028) & (K Units)
Figure 16. North America ADHD Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe ADHD Treatment Sales YoY (2017-2028) & (K Units)
Figure 18. Europe ADHD Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific ADHD Treatment Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific ADHD Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America ADHD Treatment Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America ADHD Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa ADHD Treatment Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa ADHD Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The ADHD Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of ADHD Treatment in the World: Market Share by ADHD Treatment Revenue in 2021
Figure 27. Global ADHD Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global ADHD Treatment Sales Market Share by Type (2017-2028)
Figure 29. Global ADHD Treatment Revenue Market Share by Type (2017-2028)
Figure 30. Global ADHD Treatment Sales Market Share by Distribution Channel (2017-2028)
Figure 31. Global ADHD Treatment Revenue Market Share by Distribution Channel (2017-2028)
Figure 32. North America ADHD Treatment Sales Market Share by Type (2017-2028)
Figure 33. North America ADHD Treatment Revenue Market Share by Type (2017-2028)
Figure 34. North America ADHD Treatment Sales Market Share by Distribution Channel (2017-2028)
Figure 35. North America ADHD Treatment Revenue Market Share by Distribution Channel (2017-2028)
Figure 36. North America ADHD Treatment Sales Share by Country (2017-2028)
Figure 37. North America ADHD Treatment Revenue Share by Country (2017-2028)
Figure 38. United States ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 39. Canada ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 40. Europe ADHD Treatment Sales Market Share by Type (2017-2028)
Figure 41. Europe ADHD Treatment Revenue Market Share by Type (2017-2028)
Figure 42. Europe ADHD Treatment Sales Market Share by Distribution Channel (2017-2028)
Figure 43. Europe ADHD Treatment Revenue Market Share by Distribution Channel (2017-2028)
Figure 44. Europe ADHD Treatment Sales Share by Country (2017-2028)
Figure 45. Europe ADHD Treatment Revenue Share by Country (2017-2028)
Figure 46. Germany ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 47. France ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 49. Italy ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 50. Russia ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific ADHD Treatment Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific ADHD Treatment Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific ADHD Treatment Sales Market Share by Distribution Channel (2017-2028)
Figure 54. Asia Pacific ADHD Treatment Revenue Market Share by Distribution Channel (2017-2028)
Figure 55. Asia Pacific ADHD Treatment Sales Share by Region (2017-2028)
Figure 56. Asia Pacific ADHD Treatment Revenue Share by Region (2017-2028)
Figure 57. China ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 58. Japan ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 60. India ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. Australia ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America ADHD Treatment Sales Market Share by Type (2017-2028)
Figure 67. Latin America ADHD Treatment Revenue Market Share by Type (2017-2028)
Figure 68. Latin America ADHD Treatment Sales Market Share by Distribution Channel (2017-2028)
Figure 69. Latin America ADHD Treatment Revenue Market Share by Distribution Channel (2017-2028)
Figure 70. Latin America ADHD Treatment Sales Share by Country (2017-2028)
Figure 71. Latin America ADHD Treatment Revenue Share by Country (2017-2028)
Figure 72. Mexico ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 75. Colombia ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa ADHD Treatment Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa ADHD Treatment Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa ADHD Treatment Sales Market Share by Distribution Channel (2017-2028)
Figure 79. Middle East and Africa ADHD Treatment Revenue Market Share by Distribution Channel (2017-2028)
Figure 80. Middle East and Africa ADHD Treatment Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa ADHD Treatment Revenue Share by Country (2017-2028)
Figure 82. Turkey ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 84. UAE ADHD Treatment Revenue (2017-2028) & (US$ Million)
Figure 85. ADHD Treatment Value Chain
Figure 86. ADHD Treatment Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---